Corbus Pharmaceuticals (3371.STU) Q2 2026 Earnings

12MayConfirmed
Q1 2026
Next
-1.31
-1.21
-1.12
-1.03

Details

Expected EPS
-1.0286946306
Actual EPS
N/A
Surprise EPS
1.03
Surprise Percent
+100%

Description

Corbus Pharmaceuticals (3371.STU) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts